Life sciences company Avantor (NYSE:AVTR) will be reporting earnings tomorrow before market hours. Here’s what you need to know. Avantor missed analysts’ revenue expectations by 0.7% last ...

Life sciences company Avantor (NYSE:AVTR) fell short of the market’s revenue expectations in Q4 CY2024, with sales falling 2.1% year on year to $1.69 billion. Its non-GAAP profit of $0.27 per ...

Wells Fargo analyst Brandon Couillard maintained a Buy rating on Avantor (AVTR – Research Report) today and set a price target of $28.00. The company’s shares closed last Friday at $19.16.

Avantor has a 12 month low of $19.59 and a 12 month high of $28.00. The stock has a 50 day moving average of $21.71 and a 200-day moving average of $23.47. The company has a market capitalization ...

Bernstein analyst Eve Burstein lowered the firm’s price target on Avantor (AVTR) to $22 from $24.50 and keeps a Market Perform rating on the shares following quarterly results. The firm says the ...

NEW YORK - Avantor, Inc. (NYSE:AVTR), a provider of mission-critical products and services to life sciences and advanced technology industries, reported fourth-quarter 2024 results on Friday that ...

One Chicago Wednesdays continue this fall on NBC, and that means more action from Gaffney Chicago Medical Center is coming with Chicago Med season 10. Chicago Med season 9 saw a lot of drama, from a ...